XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF NET INCOME (unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Net revenues $ 113,122 $ 103,032 $ 336,562 $ 304,848
Operating costs:        
Salaries and related costs 64,524 60,306 191,410 174,912
Rent, supplies, contract labor and other 21,654 20,600 65,598 60,720
Provision for doubtful accounts 890 930 3,102 2,716
Closure costs (22) 4 8 27
Total operating costs 87,046 81,840 260,118 238,375
Gross Profit 26,076 21,192 76,444 66,473
Corporate office costs 10,643 8,304 30,934 25,707
Operating income 15,433 12,888 45,510 40,766
Interest and other income, net 16 11 70 58
Interest expense:        
Mandatorily redeemable non-controlling interests - change in redemption value 0 (1,247) 0 (7,839)
Mandatorily redeemable non-controlling interests - earnings allocable 0 (1,285) 0 (4,366)
Debt and other (579) (641) (1,677) (1,572)
Total interest expense (579) (3,173) (1,677) (13,777)
Income before taxes 14,870 9,726 43,903 27,047
Provision for income taxes 2,991 3,132 8,734 8,029
Net income 11,879 6,594 35,169 19,018
Less: net income attributable to non-controlling interests (3,777) (1,444) (10,704) (4,111)
Net income attributable to USPH shareholders $ 8,102 $ 5,150 $ 24,465 $ 14,907
Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share) $ 0.13 $ 0.41 $ 0.88 $ 1.19
Shares used in computation - basic and diluted (in shares) 12,685 12,581 12,660 12,563
Dividends declared per common share (in dollars per share) $ 0.23 $ 0.20 $ 0.69 $ 0.60
Net Patient Revenues [Member]        
Net revenues $ 103,354 $ 96,273 $ 309,895 $ 287,584
Other Revenues [Member]        
Net revenues $ 9,768 $ 6,759 $ 26,667 $ 17,264